martes, 26 de septiembre de 2017

New Images from NCI Visuals Online

New Images from NCI Visuals Online

National Cancer Institute





09/25/2017
Dr. Francis Collins, Director of the National Institutes of Health (NIH) at the ceremony for the 2017 Lasker-DeBakey Clinical Medical Research Awards. Among the recipients were Drs. Douglas R. Lowy and John T. Schiller of the National Cancer Institute (part of NIH), for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize.
09/25/2017
Dr. John T. Schiller (left) and Dr. Douglas R. Lowy of the National Cancer Institute (NCI) accepting the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize. HPV vaccines are now used to help prevent HPV infections associated with cervical cancer and other diseases.
09/25/2017
Dr. John T. Schiller (center) of the National Cancer Institute at the ceremony for the 2017 Lasker-DeBakey Clinical Medical Research Awards. Dr. Schiller and NCI's Dr. Douglas R. Lowy received the Lasker Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize. HPV vaccines are now used to help prevent HPV infections associated with cervical cancer and other diseases.
09/25/2017
Dr. Douglas R. Lowy (center) of the National Cancer Institute at the ceremony for the 2017 Lasker-DeBakey Clinical Medical Research Awards. Dr. Lowy and NCI's Dr. John T. Schiller received the Lasker Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize. HPV vaccines are now used to help prevent HPV infections associated with cervical cancer and other diseases.
09/25/2017
Dr. Douglas R. Lowy of the National Cancer Institute at the ceremony for the 2017 Lasker-DeBakey Clinical Medical Research Awards. Dr. Lowy and NCI's Dr. John T. Schiller received the Lasker Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize. HPV vaccines are now used to help prevent HPV infections associated with cervical cancer and other diseases.
09/25/2017
Dr. John T. Schiller of the National Cancer Institute at the ceremony for the 2017 Lasker-DeBakey Clinical Medical Research Awards. Dr. Schiller and NCI's Dr. Douglas R. Lowy received the Lasker Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize. HPV vaccines are now used to help prevent HPV infections associated with cervical cancer and other diseases.
09/25/2017
Dr. John T. Schiller of the National Cancer Institute at the ceremony for the 2017 Lasker-DeBakey Clinical Medical Research Awards. Dr. Schiller and NCI's Dr. Douglas R. Lowy received the Lasker Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize. HPV vaccines are now used to help prevent HPV infections associated with cervical cancer and other diseases.
09/25/2017
Dr. Douglas R. Lowy (center) of the National Cancer Institute at the ceremony for the 2017 Lasker-DeBakey Clinical Medical Research Awards. Dr. Lowy and NCI's Dr. John T. Schiller received the Lasker Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize. HPV vaccines are now used to help prevent HPV infections associated with cervical cancer and other diseases.
09/25/2017
NCI Acting Director Dr. Douglas Lowy (far right) joined other scientists, doctors, health-care innovators, patients, and policymakers for Chasing Cancer, a two-hour summit hosted by the Washington Post where experts discussed the latest advances in cancer detection and treatment.

No hay comentarios:

Publicar un comentario